2021
DOI: 10.1016/j.biopha.2021.111573
|View full text |Cite
|
Sign up to set email alerts
|

Oncolytic viruses as a promising therapeutic strategy for hematological malignancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 171 publications
0
11
0
Order By: Relevance
“…The inclusion criteria were as follows: (1) patients diagnosed as HMs by clinical examination; (2) first chemotherapy and placement of PICC catheter; (3) patients aged more than 18 years old, primary school education and above, with certain reading comprehension ability; and (4) conscious, informed consent, and voluntary participation in this study. Exclusion criteria were as follows: (1) patients who did not support or cooperate with tumor chemotherapy in this study, (2) patients with superior vena cava syndrome and severe hemorrhagic diseases that were not suitable for catheterization, and (3) severe hearing and visual impairment.…”
Section: General Informationmentioning
confidence: 99%
See 2 more Smart Citations
“…The inclusion criteria were as follows: (1) patients diagnosed as HMs by clinical examination; (2) first chemotherapy and placement of PICC catheter; (3) patients aged more than 18 years old, primary school education and above, with certain reading comprehension ability; and (4) conscious, informed consent, and voluntary participation in this study. Exclusion criteria were as follows: (1) patients who did not support or cooperate with tumor chemotherapy in this study, (2) patients with superior vena cava syndrome and severe hemorrhagic diseases that were not suitable for catheterization, and (3) severe hearing and visual impairment.…”
Section: General Informationmentioning
confidence: 99%
“…(1) In the form of face-to-face interviews, patients and their families are asked to recall the practice of PICC self-management process during this period, and patients are encouraged to talk about the problems or worries that may exist in the current PICC self-management behavior (such as being afraid to move or excessive activity). Analyze the internal and external causes of this unhealthy behavior, such as asking the patient "what benefits do you think this will bring to you?," help patients find alternative solutions, and correct the subjective benefit of patients' bad behavior (2) In the process of intervention, we should pay attention to the important value of family members in the self-management of patients' PICC, strengthen the health education to patients' families, and weaken the formation of patients' bad health behavior caused by external factors. The intervention time was 10~15 mins…”
Section: Identify the Vein And Insertion Site (A)mentioning
confidence: 99%
See 1 more Smart Citation
“…Immunotherapies are currently used in a wide spectrum of cancers, including carcinomas ( 1 ), sarcomas ( 2 ), and hematologic malignancies ( 3 ). Viral immunotherapies are based on oncolytic viruses, which are natural or engineered viruses that selectively replicate in and kill cancer cells without harming the normal tissues.…”
Section: Introductionmentioning
confidence: 99%
“…Oncolytic virus (OV) therapy has recently been recognized as a promising therapeutic approach for cancer treatment. 4 , 5 Viruses preferentially infect, propagate, and kill tumor cells without causing damage to normal cells. 6 Over the past decade, enormous research has been reported on potential OVs and significant preclinical success.…”
Section: Introductionmentioning
confidence: 99%